- Home
- LDI vs VSTM Comparison
LDI vs VSTM Comparison
Compare LDI & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- VSTM
- Stock Information
- Founded
- LDI 2010
- VSTM 2010
- Country
- LDI United States
- VSTM United States
- Employees
- LDI N/A
- VSTM N/A
- Industry
- LDI Finance: Consumer Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- VSTM Health Care
- Exchange
- LDI Nasdaq
- VSTM Nasdaq
- Market Cap
- LDI 314.1M
- VSTM 313.1M
- IPO Year
- LDI 2021
- VSTM 2012
- Fundamental
- Price
- LDI $1.19
- VSTM $6.19
- Analyst Decision
- LDI Sell
- VSTM Strong Buy
- Analyst Count
- LDI 3
- VSTM 8
- Target Price
- LDI $2.03
- VSTM $13.00
- AVG Volume (30 Days)
- LDI 1.5M
- VSTM 949.3K
- Earning Date
- LDI 03-11-2025
- VSTM 03-20-2025
- Dividend Yield
- LDI N/A
- VSTM N/A
- EPS Growth
- LDI N/A
- VSTM N/A
- EPS
- LDI N/A
- VSTM N/A
- Revenue
- LDI $985,646,000.00
- VSTM $10,000,000.00
- Revenue This Year
- LDI $40.92
- VSTM $98.93
- Revenue Next Year
- LDI $12.46
- VSTM $231.26
- P/E Ratio
- LDI N/A
- VSTM N/A
- Revenue Growth
- LDI 5.26
- VSTM N/A
- 52 Week Low
- LDI $1.16
- VSTM $2.10
- 52 Week High
- LDI $3.23
- VSTM $13.52
- Technical
- Relative Strength Index (RSI)
- LDI 27.12
- VSTM 45.73
- Support Level
- LDI $1.33
- VSTM $6.01
- Resistance Level
- LDI $1.51
- VSTM $6.89
- Average True Range (ATR)
- LDI 0.11
- VSTM 0.48
- MACD
- LDI -0.03
- VSTM -0.11
- Stochastic Oscillator
- LDI 4.64
- VSTM 11.39
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.